Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Bleomycin × Clear all

Sponsor

Conditions

Hodgkin Disease 11 Lymphoma 9 Testicular Neoplasms 1 Teratoma 1 Sertoli-Leydig Cell Tumor 1 Recurrence 1 Ovarian gynandroblastoma 1 Ovarian Germ Cell Cancer 1 Lymphoma, Follicular 1 Granulosa cell tumor of the ovary 1 Gliosarcoma 1 Glioblastoma 1 Endodermal Sinus Tumor 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡